What Resilience does

Resilience (legal entity RESILIENCE SAS, operating as Resilience Care) is a French digital health company founded in February 2021 and headquartered in Paris that builds a digital oncology platform for remote patient monitoring. Its core medical device, Resilience PRO, is a CE 0459-marked Class IIa product that captures patient-reported symptoms and adverse events in real time and triggers automated safety alerts to oncology care teams; it is reimbursed by the French Assurance Maladie and integrated with hospital information systems via InterSystems IRIS for Health (production deployment from October 2025). The platform is complemented by the Resilience Care patient mobile application and additional modules — Advanced Analytics Platform, Advanced Clinical & Biological Data Structuring (AI-assisted), Evidence Generation Hub, and Real-World Data Explorer — and extends into gastroenterology (GutyCare) and psychiatry (Edra PRO), with manufacturing handled through wholly-owned subsidiary Resilience MD SAS in Biarritz.

The company monetizes Resilience PRO through healthcare institution subscriptions and French national reimbursement, while selling data, analytics, and real-world evidence services to pharmaceutical and biotech customers via the Evidence Generation Hub and Real-World Data Explorer. Resilience sells primarily through a direct enterprise sales motion targeting oncology centers and hospitals, and serves 200+ healthcare institutions, 1,500+ healthcare providers, and 35,000+ monitored patients across France, Belgium, and Germany, with announced expansion into the United States in March 2026 led by General Manager Greg Orr. Cumulative disclosed funding totals approximately $76 million across a 2021 seed, 2022 Series A led by Cathay Innovation with strategic participation from EXOR and hospital investors, and a 2024 round led by Picus Capital and Red River West, alongside acquisitions of Ana Health (2022) and GIMLI (2024).

Name

Resilience

Legal name

RESILIENCE SAS

Website

https://resilience.care

Company type

Private

Founded year

2021

Operating status

Operating

Headcount range

101–250 employees

Short description

Resilience Care is a French digital health company (Paris, founded 2021) that sells a CE-marked remote patient monitoring platform for oncology, gastroenterology, and psychiatry, serving 200+ hospitals and life sciences customers across Europe and expanding into the U.S.

Ownership category

akta.pro rank

Headquarters

HQ city

Paris

HQ country

France

HQ region

Europe

Offices3 records

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure

Revenue model

1. Remote Patient Monitoring (Resilience PRO): Resilience PRO, a Class IIa medical device for remote patient monitoring of cancer patients, is reimbursed by French Assurance Maladie (French national social security system). Revenue is generated through healthcare institution subscriptions and government reimbursement pathways.
2. Life Sciences Solutions: Platform services for pharmaceutical and biotech companies to inform drug development, transform clinical trials, and accelerate real-world evidence generation. Revenue from research partnerships and data access agreements.

Pricing tiers

Go-to-market motion2 records

Distribution channels4 records

Marketing channels8 records

Core offering

Resilience provides a CE-marked Class IIa digital oncology platform for remote patient monitoring of cancer patients, comprising the Resilience PRO monitoring medical device and the Resilience Care companion app. The platform captures real-time patient-reported symptoms and adverse events with automated alerts, structures clinical and biological data, and supports real-world evidence generation for healthcare providers and life sciences companies across oncology, gastroenterology, and psychiatry.

Product overview

Resilience offers a multi-module digital oncology platform with specialized solutions for oncology, gastroenterology, and psychiatry. The core platform consists of Resilience PRO (remote patient monitoring module for oncology) and the Resilience Care App (patient-centric companion application), supported by add-on modules including the Advanced Analytics Platform, Advanced Clinical & Biological Data Structuring (AI-powered), Evidence Generation Hub, and Real-World Data Explorer. The company also offers specialized sub-brands: GutyCare for gastroenterology and Edra PRO for psychiatry. All medical devices are Class IIa with CE 0459 marking. The platform integrates with hospital information systems via InterSystems IRIS and supports 200+ healthcare institutions monitoring 35,000+ patients across Europe and expanding to the U.S.

Differentiator

Problem solved

Functional benefit

Brands

• Resilience PRO: Remote patient monitoring solution indicated for oncology patients to monitor adverse events and adapt patient management. Class IIa medical device with CE 0459 marking, reimbursed by French Social Security.
• GutyCare
• Edra PRO

Products and services

• Resilience PRO Class IIa CE-marked medical device for remote patient monitoring of oncology patients, tracking symptoms and adverse events in real time with automated safety alerts to healthcare providers. Reimbursed by French Assurance Maladie.
• Resilience Care App Patient-centric mobile application providing personalized programs and content tailored to each patient's pathology, treatment, and symptoms, enabling continuous digital support and early symptom detection across oncology, gastroenterology, and psychiatry.
• Advanced Analytics Platform Intuitive dashboards for data-driven decision-making in clinical operations, enabling healthcare providers to monitor patient outcomes, identify trends, and improve care quality.
• Advanced Clinical & Biological Data Structuring AI-powered capability that structures fragmented clinical and biological data into actionable insights for clinical research, market access, publications, and improved patient stratification for precision medicine.
• Evidence Generation Hub End-to-end platform for designing and running real-world evidence studies, enabling life sciences companies to demonstrate treatment value and patient outcomes.
• Real-World Data Explorer Secure access to aggregated, de-identified data from the Resilience partner network, enabling real-time exploration and advanced analytics for clinical research purposes.
• GutyCare Class IIa CE-marked remote medical monitoring platform for gastroenterology, enabling specialist nurses to interpret health data and adapt patient care. Not reimbursed by French Assurance Maladie.
• Edra PRO Class IIa CE-marked remote monitoring and clinical decision support platform in psychiatry for adult patients experiencing major depressive or manic episodes, excluding emergency situations.

Quantifiable outcome

• 200+ healthcare institutions using the platform
• +3 more outcomes

Named customers9 records

Segments4 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration6 records

AI capability5 records

Feature7 records

Partnerships

One partnership is on record.

• InterSystemscoreTechnology or Integration · 3 March 2026Technology partnership to deploy oncology care solution using InterSystems IRIS for Health as integration layer with hospital information systems. Enables automatic synchronization of chemotherapy appointments, consultations, and lab tests while eliminating duplicate entries. Production began October 2025 with deployment underway in several healthcare facilities. Plans to extend solution to gastroenterology, psychiatry, and additional hospitals.

Scale indicators8 records

Recent moves7 records

Expansion highlights6 records

Direct peers

• Kaiku Health: Finnish digital health platform providing remote symptom monitoring for cancer patients, now part of Elekta. Directly comparable to Resilience in oncology-focused RPM, ePRO capture, and hospital integration.
• Noona: Oncology patient engagement and symptom monitoring platform, now part of Varian (a Siemens Healthineers company). Competes with Resilience in delivering ePRO-based RPM to cancer centers and life sciences partners.
• Cureety: French digital health company focused on remote monitoring and care pathways for cancer patients. Closest direct French peer to Resilience, serving similar oncology provider customers.
• Voluntis: France-based digital therapeutics company developing CE-marked software for chronic disease and oncology patient monitoring. Comparable regulatory pathway (Class IIa CE marking) and similar pharma partnership model.

Broad incumbents

• Tempus Labs: U.S.-based oncology data and AI company operating a large real-world evidence platform. Comparable to Resilience's life sciences offering through structured oncology data and pharma/biotech partnerships, though at much greater scale.
• Flatiron Health: Oncology-focused electronic health record and real-world data company (acquired by Roche). Comparable in oncology RWE monetization and clinical workflow integration with U.S. cancer centers.
• Philips (Remote Patient Monitoring): Global medtech incumbent offering RPM solutions across multiple therapy areas including oncology. Competes with Resilience on enterprise hospital deals and broader care continuum.
• Teladoc Health: Large-scale virtual care and chronic condition management platform. Adjacent in remote monitoring and chronic care, though broader and less oncology-specialized than Resilience.

Emerging players

• Huma (formerly Medopad): Digital health platform offering remote patient monitoring and decentralized clinical trial capabilities across multiple therapy areas. Comparable in RPM + DCT play, with stronger U.S. and pharma presence.

Others

• InterSystems: Healthcare data platform provider; Resilience's technology integration partner via IRIS for Health. Relevant as a strategic enabler of hospital EHR integration and adjacent ecosystem participant.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/@resilience6964
• LinkedInlinkedin.com/company/resiliencecare
• Instagraminstagram.com/resilience.care
• Xx.com/Resiliencecare

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Subsidiaries1 record

Funding overview

Funding rounds3 records

Investors10 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A3 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Resilience